<bill session="111" type="s" number="1674" updated="2013-07-20T00:38:48-04:00">
  <state datetime="2010-10-05">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2010-10-05"/>
  </status>
  <introduced datetime="2009-09-15"/>
  <titles>
    <title as="introduced" type="short">Improving Access to Clinical Trials Act of 2009</title>
    <title as="passed house" type="short">Improving Access to Clinical Trials Act of 2009</title>
    <title as="passed senate" type="short">Improving Access to Clinical Trials Act of 2009</title>
    <title as="enacted" type="short">Improving Access to Clinical Trials Act of 2009</title>
    <title as="introduced" type="official">A bill to provide for an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.</title>
  </titles>
  <sponsor id="300100"/>
  <cosponsors>
    <cosponsor id="300011" joined="2010-07-22"/>
    <cosponsor id="400050" joined="2009-09-25"/>
    <cosponsor id="300013" joined="2010-06-16"/>
    <cosponsor id="400054" joined="2010-07-15"/>
    <cosponsor id="412328" joined="2010-09-14"/>
    <cosponsor id="400576" joined="2009-09-25"/>
    <cosponsor id="300034" joined="2009-09-15"/>
    <cosponsor id="300038" joined="2009-09-16"/>
    <cosponsor id="300043" joined="2010-09-14"/>
    <cosponsor id="412378" joined="2010-07-14"/>
    <cosponsor id="300055" joined="2009-09-15"/>
    <cosponsor id="300058" joined="2010-03-04"/>
    <cosponsor id="300060" joined="2010-04-14"/>
    <cosponsor id="412242" joined="2010-06-29"/>
    <cosponsor id="300064" joined="2010-06-30"/>
    <cosponsor id="300068" joined="2010-01-27"/>
    <cosponsor id="400272" joined="2010-06-24"/>
    <cosponsor id="412325" joined="2010-06-10"/>
    <cosponsor id="300075" joined="2010-02-26"/>
    <cosponsor id="300083" joined="2010-05-20"/>
    <cosponsor id="300089" joined="2009-09-15"/>
  </cosponsors>
  <actions>
    <action datetime="2009-09-15">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S9379"/>
    </action>
    <action state="REFERRED" datetime="2009-09-15">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
    <action datetime="2010-08-05">
      <text>Senate Committee on Finance discharged by Unanimous Consent.</text>
      <reference ref="CR S6979-6980" label="consideration"/>
    </action>
    <vote state="PASS_OVER:SENATE" datetime="2010-08-05" how="by Unanimous Consent" result="pass" type="vote" where="s">
      <text>Passed Senate without amendment by Unanimous Consent.</text>
      <reference ref="CR S6979-6980" label="text"/>
    </vote>
    <action datetime="2010-08-06">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2010-08-09T19:07:00-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2010-08-09T20:39:00-04:00">
      <text>Held at the desk.</text>
    </action>
    <action datetime="2010-09-23T11:16:00-04:00">
      <text>Mr. McDermott moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2010-09-23T11:16:00-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H6891-6896" label="consideration"/>
    </action>
    <action datetime="2010-09-23T11:16:00-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on S. 1674.</text>
    </action>
    <vote state="PASSED:BILL" datetime="2010-09-23T11:41:00-04:00" how="by voice vote" result="pass" type="vote2" where="h">
      <text>On motion to suspend the rules and pass the bill Agreed to by voice vote.</text>
      <reference ref="CR H6892" label="text"/>
    </vote>
    <action datetime="2010-09-23T11:41:00-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <topresident datetime="2010-09-23">
      <text>Cleared for White House.</text>
    </topresident>
    <topresident datetime="2010-09-24">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2010-10-05">
      <text>Signed by President.</text>
    </signed>
    <enacted state="ENACTED:SIGNED" datetime="2010-10-05" type="public" number="111-255">
      <text>Became Public Law No: 111-255.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" activity="Referral, Discharged"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="111" type="h" number="2866"/>
  </relatedbills>
  <subjects>
    <term name="Social welfare"/>
    <term name="Medicaid"/>
    <term name="Medical research"/>
    <term name="Poverty and welfare assistance"/>
  </subjects>
  <amendments/>
  <summary>10/5/2010--Public Law.
(This measure has not been amended since it was introduced. The summary of that version is repeated here.) Improving Access to Clinical Trials Act of 2009 - Amends title XVI (Supplemental Security Income) (SSI) of the Social Security Act (SSA) to exclude from income for SSI eligibility purposes any compensation in the amount of the first $2,000 per year received by an individual for participation in clinical trials involving research and testing of treatments for rare diseases or conditions. Amends SSA title XIX (Medicaid) to make a similar exclusion from income of such compensation for the purposes of eligibility under the Medicaid program. Directs the Comptroller General to study and report to Congress on the impact of this Act on enrollment of individuals who receive SSI benefits in clinical trials for rare diseases or conditions.</summary>
</bill>
